-
Ravuconazole (codenamed BMS-207147 and ER-30346) is a
potent triazole antifungal, the
development of
which was
discontinued in 2007. The drug has shown...
- Second-generation triazoles,
including voriconazole,
posaconazole and
ravuconazole, are more
potent and more
active against resistant pathogens. This article...
-
Epoxiconazole Fluconazole Isavuconazole Itraconazole Posaconazole Propiconazole Ravuconazole Terconazole Voriconazole Abafungin Allylamines inhibit squalene epoxidase...
-
fungal infection of the nail. It is a
prodrug that is
converted into
ravuconazole.
Drugs for
Neglected Diseases Initiative (DNDi) and the ****anese pharmaceutical...
- fluconazole, isavuconazole, itraconazole, voriconazole, pramiconazole,
ravuconazole, and
posaconazole and
triazole plant-protection
fungicides include epoxiconazole...
-
marketed drugs anastrozole, fadrozole, bicalutamide, dexmedetomidine,
ravuconazole, and posaconazole, have been
proposed as
potential adjuvant therapies...
-
quinazamid quinconazole quinofumelin quinoxyfen quintozene rabenzazole ravuconazole saijunmao saisentong salicylanilide sanguinarine santonin seboctylamine...
- van de (19 June 2014). "Madurella
mycetomatis Is
Highly Susceptible to
Ravuconazole". PLOS Negl Trop Dis. 8 (6): e2942. doi:10.1371/journal.pntd.0002942...
-
multiple myeloma.
Clinical trials have been
performed on
posaconazole and
ravuconazole for
Chagas disease.
Other antifungal agents clotrimazole and ketoconazole...
-
against C.
tropicalis are itraconazole, voriconazole, posaconazole,
ravuconazole and isavuconazole.
Voriconazole is a new
generation from fluconazole...
